Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview
Explore Amphastar Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Amphastar Pharmaceuticals, Inc. (AMPH)
Key Financials
Key Financials
Market Cap
885.8M
P/E Ratio
11.57
EPS (TTM)
$1.66
ROE
0.10%
AMPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Amphastar Pharmaceuticals, Inc. (AMPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 55.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.50.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.57 and a market capitalization of 885.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.